Study on VR-relaxation for ECT-related Anxiety, NCT07546526
Summary
A new clinical trial registration on ClinicalTrials.gov (NCT07546526) studying whether Virtual Reality (VR)-based relaxation reduces anxiety in patients receiving electroconvulsive therapy (ECT) as part of routine clinical care. Researchers will compare VR-relaxation, breathing exercises, and treatment as usual as interventions, measuring ECT-related anxiety, stress symptoms, and heart rate as outcomes.
“The goal of this clinical trial is to learn if there is an effect of Virtual Reality (VR) based-relaxation on electroconvulsive therapy (ECT)-related anxiety.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This document registers a new clinical trial (NCT07546526) on ClinicalTrials.gov investigating whether Virtual Reality (VR)-based relaxation reduces anxiety in patients undergoing electroconvulsive therapy (ECT). The trial has three arms: VR-relaxation, breathing exercises, and treatment as usual, with anxiety, stress symptoms, and heart rate as measured outcomes.
Healthcare institutions conducting ECT, clinical investigators, and IRB/Ethics committees should note this trial as an emerging non-pharmacological adjunct for anxiety management in psychiatric settings. Trial sponsors must ensure compliance with applicable FDA clinical trial registration and reporting requirements.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
VR-relaxation for ECT-related Anxiety
N/A NCT07546526 Kind: NA Apr 22, 2026
Abstract
The goal of this clinical trial is to learn if there is an effect of Virtual Reality (VR) based-relaxation on electroconvulsive therapy (ECT)-related anxiety. The main questions it aims to answer are:
- Does VR based-relaxation have an effect on anxiety in patients receiving ECT as part of routine clinical care?
- Does VR based-relaxation have an effect on stress symptoms and heart rate in patients receiving ECT as part of routine clinical care?
- Does depression severity have an effect on the effectivity of VR-based relaxation
Researchers will compare VR-relaxation to relaxation breathing exercises and no relaxation to see if VR-based relaxation has an effect on ECT-related anxiety.
Conditions: ECT-related Anxiety
Interventions: VR-based relaxation, Breathing exercises, Treatment as usual
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.